Innovations in Fluid Management for Dialysis Patients

Introduction

Fluid volume and hemodynamic control in hemodialysis (explain) patients are crucial for dialysis adequacy. Achieving salt and water balance in these patients has long been a primary concern for nephrologists, often addressed through the determination of 'dry weight.' While this clinical approach has shown cardiovascular benefits, recent research challenges its intensity, suggesting that aggressive fluid removal during intermittent dialysis may lead to cardiovascular strain and potential organ damage.

Therefore, a more refined approach is needed to enhance cardiovascular outcomes in this high-risk population. Assessing and monitoring fluid status rely on four key elements: clinical evaluation, non-invasive tools, such as ultrasound and bioimpedance analysis, cardiac biomarkers like natriuretic peptides, and algorithms combined with sodium modeling to estimate mass transfer.

The optimal management of fluid and sodium imbalances in dialysis patients involves adjusting salt and fluid removal during dialysis sessions (through ultrafiltration and dialysate sodium concentration) and implementing salt intake and fluid intake restrictions between sessions. Advanced technologies integrating biosensors and feedback control mechanisms into dialysis machines and sophisticated analytics promise more precise and personalized handling of sodium and water levels.

What Are Innovations in Fluid Management for Dialysis Patients?

Optimal fluid volume management in dialysis patients is crucial for effective dialysis, yet managing the extent of volume fluctuation remains a significant clinical challenge. Since the 1960s, nephrologists have persistently pursued the goal of restoring salt and water balance in hemodialysis patients.

Salt and water management in these patients is commonly addressed using the 'dry weight' method. Although this approach has shown cardiovascular benefits, recent studies suggest that the aggressive removal of fluid during conventional thrice-weekly dialysis sessions may cause excessive hemodynamic stress and potential organ damage, leading to long-term adverse effects.

Therefore, while the 'dry weight' strategy is clinically necessary, it is insufficient from a pathophysiological standpoint to ensure comprehensive cardiovascular protection in dialysis patients. A more balanced and precise method is needed to improve cardiovascular outcomes in this high-risk group. To meet this need, it is crucial to adopt a broader strategy that encompasses the overall hemodynamic management of dialysis patients rather than focusing solely on fluid management.

The following are the innovations in fluid management for dialysis patients:

• Intermittent renal replacement therapy subjects dialysis patients to ongoing and repetitive hemodynamic stress explain). This stress arises from the treatment's sporadic nature, causing fluid volume fluctuations between the interdialytic (periods between treatments) and intradialytic (during treatments) phases.

• This phenomenon is encapsulated by the "unphysiological profile" of short, intermittent dialysis sessions. Mechanistically, two distinct stress conditions can be identified: first, a chronic hemodynamic stress phase characterized by extracellular fluid accumulation and chronic fluid overload during the interdialytic period; second, an acute hemodynamic stress phase caused by intravascular fluid depletion during dialysis sessions due to ultrafiltration and sodium removal. This acute phase can result in critical hypovolemia (explain), hypotensive episodes (explain), and impaired organ perfusion.

• Sodium and fluid accumulation in dialysis patients over time due to repetitive positive fluid imbalances leads to chronic extracellular fluid overload. This overload has detrimental effects, particularly on cardiovascular health, resulting in poor outcomes.

• Poor fluid management and extracellular fluid overload are fundamental causes of cardiovascular complications in hemodialysis patients.

• Hypertension (high blood pressure), a component of these disorders, is widely recognized as a major contributor to left ventricular cardiomyopathy (explain) and accelerated atherosclerosis (explain), including coronary artery disease, peripheral artery disease, and cerebrovascular disease.

• A recent large cohort study indicated that fluid overload alone has an independent and additively harmful effect on blood pressure (low or high), exacerbating the overall negative impact on patient outcomes. Additionally, hyponatremia (explain), though not fully understood, is linked to poor outcomes in dialysis patients.

• Managing sodium and fluid excess to restore fluid homeostasis, whether through moderate or high ultrafiltration rates or a high plasma-to-dialysate sodium concentration gradient, can lead to critical hypovolemia and is associated with an increased mortality risk. The combination of these factors significantly amplifies their negative impact on patient outcomes.

What Is Fluid Management in Dialysis Patients?

The following are the fluid management practices of dialysis patients:

• The initial approach to addressing fluid management in dialysis patients involved clinical assessments focusing on fluid status, hemodynamic stability, and patient perception, which led to the development of the 'dry weight' concept.

• Dry weight refers to the post-dialysis weight at which the patient theoretically has no signs of fluid imbalance, neither excess nor depletion, maintains normal blood pressure for their clinical condition, and feels comfortable without functional limitations.

• Clinicians probe and periodically reassess 'dry weight' over time based on patient conditions, changes, or intercurrent events to maintain fluid balance. Subsequent research has further refined the 'dry weight' concept assessment.

• Instrumental or technology-based tools use various non-invasive methods to assess volemia, fluid status, or hemodynamic surrogate indicators. One proposed method is measuring the inferior vena cava diameter (IVCD) and its collapsibility to monitor intravascular volume and proper atrial or central venous pressure in dialysis patients, yielding some interesting results.

• However, practical difficulties in implementing these methods in dialysis facilities and their poor predictive value for blood pressure response when probing dry weight have limited their widespread use. Nonetheless, recent data in critically ill patients indicated that IVCD collapsibility had a reasonable predictive value (c-statistic 0.72) for tolerance to fluid removal.

• Cardiac and vascular biomarkers have been widely used to distinguish fluid status from cardiac dysfunction in dialysis patients. Atrial natriuretic peptides (ANP, BNP, and NT-proBNP) are the most commonly used markers for assessing fluid overload. Conversely, copeptin (a vasopressin precursor) is more indicative of fluid depletion.

• Additionally, cardiovascular biomarkers that reflect cardiac or endothelial injury are valuable for developing a more precise and personalized approach to fluid management. Sensitive troponin markers (troponin I and T) detect critical myocardial hypoperfusion (explain).

• Optimal management of fluid and sodium imbalance in dialysis patients involves regulating salt and fluid removal during dialysis, restricting salt intake, and controlling fluid gain between sessions. This conventional approach adjusts 'dry weight' based on clinical judgment and additional tools, such as adapting the dialysate sodium prescription.

• However, this method can be limited by hemodialysis's intermittent nature and patients' intolerance to fluid and sodium removal. A potential solution is to increase the duration and frequency of dialysis sessions for patients with significant interdialytic weight gains or intolerance to fluid removal, as this can reduce intradialytic hemodynamic stress.

• However, increasing dialysis frequency or duration may only sometimes be feasible due to financial or logistical constraints or patient preference.

Conclusion

The concept of dialysis adequacy has evolved based on patient outcomes. With more efficient hemodialyzers, advanced hemodialysis machines, and the widespread use of ultrapure dialysis fluid, the efficiency and biocompatibility of renal replacement therapy have significantly improved. Ensuring cardioprotective hemodialysis requires prioritizing sodium and fluid management.

However, achieving extracellular volume homeostasis, proper blood pressure control, and maintaining hemodynamic stability in dialysis patients remains challenging. The approach to managing sodium and fluid balance in dialysis patients is shifting from the simplistic dry weight method to a more precise strategy supported by new diagnostic and monitoring tools. This evolution is set to advance further with the advent of intelligent hemodialysis machines that offer direct control of dialysis sodium and water handling, along with advanced technology and analytics.